id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2206800,4e1ca9e2-e9a5-452f-aaa9-e12bef1ed9e0,Q3,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",4653,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",2018,third_quarter,TAX,"Discussions with members of the Senate and House of Representatives on reform of the tax code, including draft proposals that would change the tax deductibility of advertising expenses 
Proposals to end the tax deduction for expenses for direct-to-consumer prescription drug advertising, including an amendment to H.R. 1 that would eliminate the deduction for prescription drug advertising expenses
S.771 & H.R. 1776:  Improving Access to Affordable Prescription Drugs Act, section 405 which would eliminate the tax deduction for expenses related to direct-to-consumer prescription drug advertising
S. 2478: End Taxpayer Subsidies for Drug Ads Act, to disallow the tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs","Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Telecommunications & Information Administration (NTIA),SENATE,Treasury, Dept of",,430000,0,0,2018-10-22T13:28:51.537000-04:00